当前位置: 首页 >> 检索结果
共有 7372 条符合本次的查询结果, 用时 2.440547 秒

321. Sex and gender policies mark a step change for medical research.

作者: Alice Witt.;Helena Legido-Quigley.;Jane E Hirst.;Ophira Ginsburg.;Kate Womersley.
来源: Lancet. 2026年407卷10523期24-25页

322. Global burden of disease from intimate partner violence against women and sexual violence against children: a call to action.

作者: Rachel Jewkes.;Naeemah Abrahams.
来源: Lancet. 2026年407卷10523期2-3页

323. Nick Fox: new opportunities to support people with dementia.

作者: Niall Boyce.
来源: Lancet. 2026年407卷10523期19页

324. Offline: Watching the watchers (part 4).

作者: Richard Horton.
来源: Lancet. 2026年407卷10523期14页

325. No health without peace.

作者: The Lancet.
来源: Lancet. 2026年407卷10523期1页

326. Socioeconomic inequalities in cancer survival and access to health care among children and adolescents in China, 2018-24: a prospective nationwide cohort study.

作者: Xin Ni.;Zhe Li.;Yingying Liu.;Xinping Li.;Guoliang Bai.;Ming Lu.;Zhuoyu Yang.;Xin Xu.;Wei Zhao.;Kar Keung Cheng.;Yaoguang Zhang.;Rongshou Zheng.;Yuanhu Liu.;Chenguang Jia.;Xiaoning Wang.;Yifei Wang.;Qingnan Shi.;Xingfeng Yao.;Yawei Zhang.;Yan Su.;Shengcai Wang.;Zhuo Deng.;Wei Yang.;Yanlong Duan.;Ruidong Zhang.;Xiaoyu Wang.;Huawei Mao.;Shuling Liu.;Jiayi Li.;Tianwei Zhang.
来源: Lancet. 2026年407卷10525期237-255页
To improve health equity, as a Sustainable Development Goal, timely evaluation of inequalities in cancer survival is essential. We aimed to assess the latest nationwide 5-year survival for childhood and adolescent cancers in China and disparities in survival, especially those associated with health-care access.

327. National data for global 2030 targets for childhood cancer.

作者: Catherine G Lam.;Scott C Howard.
来源: Lancet. 2026年407卷10525期196-197页

328. In search of rest-Kerry James Marshall: The Histories.

作者: Rochelle A Burgess.
来源: Lancet. 2025年

329. Announcing the Lancet Commission on Maternal and Newborn Health.

作者: Mehreen Zaigham.;Gerard H A Visser.;Hadiza Galadanci.; .
来源: Lancet. 2026年407卷10528期556-557页

330. Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.

作者: Jean Bourhis.;Anne Aupérin.;Christian Borel.;Gautier Lefebvre.;Severine Racadot.;Lionnel Geoffrois.;Xu Shan Sun.;Esma Saada.;Beatriz Cirauqui.;Tomasz Rutkowski.;Stephanie Henry.;Anouchka Modesto.;Alison Johnson.;Sophie Chapet.;Benoit Calderon.;Christian Sire.;Olivier Malard.;Matthieu Bainaud.;Antonio Da Silva Motta.;Sebastien Thureau.;Yoann Pointreau.;Pierre Blanchard.;Guillaume Buiret.;Laurence Bozec.;Stephane Lopez.;Julie Vanbockstael.;Matthieu Bosset.;Charlotte Greilsamer.;Amaury Daste.;Antoine Bruna.;France N'Guyen.;Maria Plana.;Eluska Iruarrizaga.;Stephane Temam.;Caroline Even.;Elisabeth Perez Ruiz.;Mahasti Bert.;Eleni Karamouza.;Juliette Thariat.;Joanna Kazmierska.;Amanda Psyrri.;Ricard Mesia.;Yungan Tao.
来源: Lancet. 2026年407卷10526期363-374页
Postoperative cisplatin and radiotherapy is the standard of care for high-risk resected locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). The NIVOPOST-OP trial aimed to assess the efficacy and safety of programmed death 1 blockade by nivolumab added to cisplatin and radiotherapy in this setting.

331. Inclusion of women who are pregnant, lactating, or of reproductive potential in clinical trials: health, ethical, and regulatory considerations.

作者: Lana Moayad.;Ariana Mihan.;Sanne A E Peters.;Harriette G C Van Spall.
来源: Lancet. 2025年406卷10521期2858-2864页
Randomised controlled trials have commonly excluded women who are pregnant, lactating, or of reproductive potential. When there is clinical equipoise, the exclusion of these women raises concerns regarding the principles of autonomy, beneficence, and justice. This exclusion also shifts evidence generation from the monitored setting of randomised controlled trials to clinical settings, where data can take several years to accrue. Here, we highlight key health, ethical, scientific, and regulatory considerations surrounding the inclusion of women who are pregnant, lactating, or of reproductive potential in clinical trials to guide further discussions. We offer recommendations for a judicious approach to inclusivity, highlighting regulatory, sponsor, and clinical trial design considerations. We highlight the need for patient engagement and interdisciplinary discourse throughout the research lifecycle.

333. Fetal and maternal outcomes following mpox infection in pregnancy.

作者: Akaninyene Eseme Ubom.;Sebastine Oseghae Oiwoh.
来源: Lancet. 2026年407卷10525期198-199页

334. Impact of anti-immigration measures on health.

作者: Michael Liu.;Vishal R Patel.;Marcos Gomez Ambriz.;David E Velasquez.;Rishi K Wadhera.
来源: Lancet. 2026年407卷10523期23-24页

335. Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort study.

作者: Emmanuel Hasivirwe Vakaniaki.;Isaac Barhishindi.;Ange Mubiala.;Espoir Bwenge Malembaka.;Lydia Braunack-Mayer.;Bruce Nganga.;Sabin Sabiti Nundu.;Isabel Brosius.;Stefanie Bracke.;Eugene Bangwen.;Elise De Vos.;Robert Colebunders.;Mireille Ngale.;Gabriel Kayembe.;Christian Tshongo.;Ali Dilu.;Celestin Tshimanga.;Jean-Luc Biampata.;Patrick Musole Bugeme.;Nsengi Ntamabyaliro.;Bruce Kirenga.;Misaki Wayengera.;Joseph Nelson Siewe Fodjo.;David Lupande Mwenebitu.;Anne W Rimoin.;Tony Wawina-Bokalanga.;Koen Vercauteren.;Daniel Mukadi-Bamuleka.;Jean-Jacques Muyembe-Tamfum.;Susanne Krasemann.;Jason Kindrachuk.;Andrew S Azman.;Veronique Nussenblatt.;Ian Crozier.;Lori E Dodd.;Olivier Tshiani-Mbaya.; .; .; .; .;Nicola Low.;Patrick D M C Katoto.;Placide Mbala-Kingebeni.;Laurens Liesenborghs.
来源: Lancet. 2026年407卷10525期256-266页
Monkeypox virus (MPXV) has been linked to vertical transmission, but systematic data are scarce. We aimed to describe the sociodemographic, clinical, and virological characteristics and assess the frequency and determinants of adverse outcomes in pregnant women with MPXV clade I infection.

336. Home.

作者: Donna Wakefield.
来源: Lancet. 2026年406卷10522期2989-2990页

338. The diabetic foot after SWHSI-2: healing is not one size fits all - Authors' reply.

作者: Catherine Arundel.;Laura Mandefield.;Caroline Fairhurst.;Athanasios Gkekas.;Ian Chetter.
来源: Lancet. 2026年406卷10522期2925-2926页

339. The diabetic foot after SWHSI-2: healing is not one size fits all.

作者: Prashanth Vas.;Patrick Chong.
来源: Lancet. 2026年406卷10522期2924-2925页

340. The need for metabolic health stratification in global obesity forecasts - Authors' reply.

作者: Simon I Hay.;Marie Ng.;Emmanuela Gakidou.;Christopher J L Murray.
来源: Lancet. 2026年406卷10522期2923-2924页
共有 7372 条符合本次的查询结果, 用时 2.440547 秒